erectile dysfunction end stage renal disease haemodialysis kidney transplant Erectile Dysfunction Kidney Failure, Chronic Renal Dialysis Kidney Transplantation
Conditions
Interventions
End-stage renal disease patients undergoing haemodialysis receive 5 mg of tadalafil every three days and are evaluated every 2 to 4 weeks.,End-stage renal disease patients who underwent unilateral kid
Active Comparator Drug,Active Comparator Drug,Active Comparator Drug
Haemodialysis,First time kidney transplantation,non-First time kidney transplantation
Sponsors
Urology-Nephrology Research Center of Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. End stage renal disease with any kind of renal replacement therapy (haemodialysis or kidney transplantation), 2. Erectile dysfunction
Exclusion criteria
Exclusion criteria: 1. Cognitive impairment, 2. Communication impairment, 3. Genital anatomical deformity, 4. Time from last transplant of less than 6 months, 5. Taking drugs causing erectile dysfunction (e.g. beta-blockers, tricyclic antidepressants), 6. Taking nitrate derivatives and nitric oxide donors, 7. Not prepared to discontinue other erectile dysfunction treatments in the coarse of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erectile Function at 4 weeks of initiating medication consumption International Index of Erectile Function 15 score | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache at 4 weeks of initiating medication consumption Pain scale chart | — |
Countries
Iran
Contacts
Public ContactMehdi Dehghani
Urology-Nephrology Research Center
Outcome results
None listed